Legal & General Group Plc - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 97 filers reported holding BRIDGEBIO PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q2 2024$4,276,793
-11.9%
168,843
+7.6%
0.00%0.0%
Q1 2024$4,854,039
+24.0%
156,987
+61.9%
0.00%0.0%
Q4 2023$3,914,477
+60.1%
96,965
+4.6%
0.00%0.0%
Q3 2023$2,445,211
+52.1%
92,727
-0.8%
0.00%0.0%
Q2 2023$1,607,943
+12.0%
93,485
+8.0%
0.00%0.0%
Q1 2023$1,435,116
+126.7%
86,557
+4.2%
0.00%
Q4 2022$633,055
-22.4%
83,078
+1.3%
0.00%
Q3 2022$816,000
-17.0%
82,029
-24.2%
0.00%
Q2 2022$983,000
+14.2%
108,275
+27.7%
0.00%
Q1 2022$861,000
-39.8%
84,764
-1.2%
0.00%
Q4 2021$1,431,000
-61.7%
85,781
+7.5%
0.00%
-100.0%
Q3 2021$3,739,000
-8.0%
79,790
+19.7%
0.00%0.0%
Q2 2021$4,063,000
+10.9%
66,650
+12.0%
0.00%0.0%
Q1 2021$3,665,000
+4.7%
59,502
+20.9%
0.00%0.0%
Q4 2020$3,501,000
+124.4%
49,232
+18.4%
0.00%0.0%
Q3 2020$1,560,000
+164.4%
41,575
+129.2%
0.00%
Q2 2020$590,000
+90.3%
18,141
+58.0%
0.00%
Q1 2020$310,000
+98.7%
11,481
+158.3%
0.00%
Q4 2019$156,000
+95.0%
4,445
+19.7%
0.00%
Q3 2019$80,000
+3900.0%
3,714
+6532.1%
0.00%
Q2 2019$2,000560.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$373,797,00067.28%
Darwin Global Management, Ltd. 2,090,149$128,753,00025.21%
Affinity Asset Advisors, LLC 577,500$35,574,00012.08%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$1,913,356,0009.64%
Perceptive Advisors 7,756,928$477,827,0006.04%
Opaleye Management Inc. 583,767$35,960,0005.28%
MIZUHO MARKETS AMERICAS LLC 171,923$10,590,0004.93%
VIKING GLOBAL INVESTORS LP 26,620,991$1,639,853,0004.88%
Fernwood Investment Management, LLC 151,085$9,307,0003.42%
HHLR ADVISORS, LTD. 5,362,014$330,300,0003.26%
View complete list of BRIDGEBIO PHARMA INC shareholders